Further, although Ezh2 deficiency did not affect the capacity of Pmel-1 cells to produce IFN-γ during the effector phase (7 days), it caused a reduction of IFN-γ-producing cells by 35 days (Fig. 1c), suggesting an impaired persistence of tumor-reactive T cells. Here, EZH2 is linked to neoplasm.